SEC Form 4 · accession 0001209191-16-139221
Insight Molecular Diagnostics Inc. · IMDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Don M Bailey
Director
Period of report
Aug 29, 2016
Accepted (ET)
Aug 30, 2016 · 8:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001642380
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase Common StockF1 | $4.02 | Aug 29, 2016 | A | 20,000 | A | — | Aug 28, 2026 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1Will become exercisable in four equal installments at the end of each calendar quarter based upon continued service on the board of directors from the date of grant.